Third Harmonic Bio Inc
NASDAQ:THRD
Intrinsic Value
The intrinsic value of one THRD stock under the Base Case scenario is 6.32 USD. Compared to the current market price of 5.38 USD, Third Harmonic Bio Inc is Undervalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Third Harmonic Bio Inc
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
Third Harmonic Bio Inc
Balance Sheet Decomposition
Third Harmonic Bio Inc
Current Assets | 276m |
Cash & Short-Term Investments | 271.6m |
Other Current Assets | 4.4m |
Non-Current Assets | 3.8m |
PP&E | 3m |
Other Non-Current Assets | 877k |
Free Cash Flow Analysis
Third Harmonic Bio Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Third Harmonic Bio Inc
Revenue
|
0
USD
|
Operating Expenses
|
-66.3m
USD
|
Operating Income
|
-66.3m
USD
|
Other Expenses
|
12.9m
USD
|
Net Income
|
-53.4m
USD
|
THRD Profitability Score
Profitability Due Diligence
Third Harmonic Bio Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Third Harmonic Bio Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
THRD Solvency Score
Solvency Due Diligence
Third Harmonic Bio Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Third Harmonic Bio Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
THRD Price Targets Summary
Third Harmonic Bio Inc
According to Wall Street analysts, the average 1-year price target for THRD is 3.06 USD with a low forecast of 3.03 USD and a high forecast of 3.15 USD.
Dividends
Current shareholder yield for THRD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one THRD stock under the Base Case scenario is 6.32 USD.
Compared to the current market price of 5.38 USD, Third Harmonic Bio Inc is Undervalued by 15%.